X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-14 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | P - Purchase | $0.00 | +5,434 | 62,058 | +10% | +$0 | ||||||
2024-03-14 | AGL | Venkatachaliah Girish | CTO | P - Purchase | $0.00 | +5,434 | 39,950 | +16% | +$0 | ||||||
2024-03-14 | AGL | Shaker Benjamin | Chief Markets Officer | P - Purchase | $0.00 | +274,455 | 258,732 | -1746% | +$0 | ||||||
2024-03-14 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | P - Purchase | $0.00 | +11,956 | 306,641 | +4% | +$0 | ||||||
2024-03-14 | AGL | Bensley Timothy | CFO | P - Purchase | $0.00 | +14,945 | 43,365 | +53% | +$0 | ||||||
2023-11-29 | AGL | Schwaneke Jeffrey A. | Dir | P - Purchase | $11.22 | +22,300 | 31,931 | +232% | +$250,206 | ||||||
| DM | 2023-09-12 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $18.03 | -37,500 | 79,543 | -32% | -$675,936 | |||||
| D | 2023-09-11 | AGL | Gertsch Timothy | Chief Accounting Officer | S - Sale+OE | $18.61 | -26,250 | 17,121 | -61% | -$488,616 | |||||
| DM | 2023-08-14 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $18.41 | -37,500 | 79,543 | -32% | -$690,392 | |||||
| DM | 2023-07-12 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $16.95 | -37,500 | 79,543 | -32% | -$635,606 | |||||
| DM | 2023-06-14 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $18.65 | -37,500 | 79,543 | -32% | -$699,249 | |||||
2023-05-18 | AGL | Cd&R Investment Associates Ix, Ltd. | 10% | S - Sale | $20.80 | -94,173,804 | 100,000,000 | -48% | -$1,958,937,549 | ||||||
| DM | 2023-05-15 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $23.47 | -50,000 | 79,543 | -39% | -$1,173,268 | |||||
| D | 2023-05-09 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | S - Sale+OE | $26.15 | -4,500 | 299,585 | -1% | -$117,666 | |||||
| DM | 2023-04-19 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | S - Sale+OE | $26.84 | -5,500 | 299,585 | -2% | -$147,618 | |||||
| DM | 2023-04-17 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $27.89 | -50,000 | 79,543 | -39% | -$1,394,727 | |||||
| DM | 2023-03-23 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | S - Sale+OE | $28.70 | -120,000 | 276,729 | -30% | -$3,444,290 | |||||
| DM | 2023-03-22 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $27.94 | -16,188 | 55,426 | -23% | -$452,354 | |||||
| D | 2023-03-15 | AGL | Wulf John William | Dir | S - Sale+OE | $23.82 | -80,000 | 123,392 | -39% | -$1,905,224 | |||||
| DM | 2023-03-15 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $24.33 | -85,000 | 60,625 | -58% | -$2,068,204 | |||||
| D | 2023-03-15 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $23.81 | -55,000 | 55,426 | -50% | -$1,309,424 | |||||
| D | 2023-03-16 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | S - Sale+OE | $26.09 | -60,000 | 276,729 | -18% | -$1,565,196 | |||||
| DM | 2023-03-07 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $24.40 | -16,188 | 10,426 | -61% | -$395,018 | |||||
| DM | 2023-02-14 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $23.12 | -78,555 | 25,625 | -75% | -$1,816,402 | |||||
| DM | 2023-02-14 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $22.98 | -33,975 | 10,426 | -77% | -$780,905 | |||||
| DM | 2023-02-01 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $22.80 | -36,178 | 10,426 | -78% | -$824,981 | |||||
| DM | 2023-01-19 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $19.79 | -16,188 | 10,426 | -61% | -$320,439 | |||||
| DM | 2023-01-17 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $19.85 | -46,445 | 25,625 | -64% | -$922,114 | |||||
| DM | 2023-01-05 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $15.48 | -5,396 | 10,426 | -34% | -$83,547 | |||||
| DM | 2022-12-15 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $17.12 | -10,796 | 10,426 | -51% | -$184,820 | |||||
| DM | 2022-12-14 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $17.39 | -37,500 | 25,625 | -59% | -$652,153 | |||||
| DM | 2022-12-05 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $17.76 | -10,796 | 10,426 | -51% | -$191,711 | |||||
2022-11-18 | AGL | Sell Steven | CEO, Pres | P - Purchase | $17.14 | +2,900 | 51,665 | +6% | +$49,705 | ||||||
| DM | 2022-11-16 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $17.73 | -37,500 | 25,625 | -59% | -$664,965 | |||||
| DM | 2022-11-16 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $17.97 | -10,792 | 10,426 | -51% | -$193,974 | |||||
| DM | 2022-11-01 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $19.78 | -10,792 | 10,426 | -51% | -$213,500 | |||||
| AM | 2022-10-19 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale | $20.17 | -50,000 | 25,625 | -66% | -$1,008,308 | |||||
| DM | 2022-10-19 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $20.17 | -50,000 | 25,625 | -66% | -$1,008,308 | |||||
| DM | 2022-10-14 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $21.79 | -10,792 | 10,426 | -51% | -$235,154 | |||||
| DM | 2022-10-03 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $23.72 | -16,188 | 10,426 | -61% | -$383,969 | |||||
| DM | 2022-09-26 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $22.86 | -16,188 | 10,853 | -60% | -$370,043 | |||||
| DM | 2022-09-08 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $22.82 | -21,584 | 10,853 | -67% | -$492,467 | |||||
| DM | 2022-08-23 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $20.69 | -10,792 | 10,853 | -50% | -$223,328 | |||||
2022-08-11 | AGL | Cd&R Investment Associates Ix, Ltd. | 10% | S - Sale | $24.35 | -11,337,500 | 194,611,308 | -6% | -$276,068,125 | ||||||
| DM | 2022-08-04 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $25.02 | -16,188 | 10,853 | -60% | -$405,072 | |||||
| D | 2022-07-21 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | S - Sale+OE | $27.50 | -79,768 | 278,211 | -22% | -$2,193,620 | |||||
| DM | 2022-07-20 | AGL | Shaker Benjamin | Chief Markets Officer | S - Sale+OE | $27.05 | -100,000 | 27,132 | -79% | -$2,704,929 | |||||
| DM | 2022-07-15 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $26.41 | -16,188 | 10,853 | -60% | -$427,519 | |||||
| D | 2022-07-07 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | S - Sale+OE | $25.00 | -319,071 | 278,211 | -53% | -$7,976,775 | |||||
| DM | 2022-07-01 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $22.83 | -46,583 | 10,853 | -81% | -$1,063,662 | |||||
| D | 2022-06-24 | AGL | Desai Veeral | Chief Strategy, Dev. Officer | S - Sale+OE | $22.50 | -106,357 | 278,211 | -28% | -$2,393,033 | |||||
| DM | 2022-06-22 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $19.98 | -10,792 | 10,853 | -50% | -$215,620 | |||||
| DM | 2022-06-09 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $20.11 | -10,792 | 10,853 | -50% | -$217,063 | |||||
| DM | 2022-05-27 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $19.67 | -10,792 | 10,853 | -50% | -$212,321 | |||||
2022-05-25 | AGL | Smith Michael L | Dir | S - Sale | $19.53 | -145,874 | 163,118 | -47% | -$2,849,459 | ||||||
| DM | 2022-05-10 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $16.21 | -10,792 | 10,853 | -50% | -$174,933 | |||||
| DM | 2022-04-27 | AGL | Kornitzer Benjamin | Chief Med., Quality Officer | S - Sale+OE | $18.49 | -10,792 | 10,853 | -50% | -$199,510 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |